Newly formed Scientific Advisory Board will support and advise the company towards submission of in IND and a First-in-Human Clinical Study of AGS-499 for ALS BE’ER SHEVA, Israel, June 23, 2022 /PRNewswire/ — Neuromagen Pharma Ltd., a company developing a new class of drugs for the…
Neuromagen Pharma Announces the Appointment of Professor Gal Ifergane, Head of the Neurology Department at Soroka Medical Center, to its Scientific Advisory Board
